primary systemic amyloidosis
primary systemic amyloidosis
Explore linked clinical trials. Standard reference: MONDO:00178165 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary systemic amyloidosis, proteostasis deficiencies | Recruiting | Phase 1 | 2026-07-24 | NCT05951816 | |
| Hungarian National Systemic Amyloidosis Registry | Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, immune system disorder, immunoproliferative disorder, inborn errors of metabolism, inherited neurodegenerative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, plasma cell neoplasm, primary systemic amyloidosis, proteostasis deficiencies | Recruiting | Not stated | 2026-07-08 | NCT07689331 | |
| Early Detection of Amyloidosis in Monoclonal Gammopathy Using Nuclear Medicine Imaging | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, neoplasm, plasma cell neoplasm, primary systemic amyloidosis, proteostasis deficiencies, vascular disorder, vascular hemostatic disease | Not yet recruiting | Not applicable | 2026-06-03 | NCT07624760 | |
| Rapid dFLC Response Predict CHR in AL Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary systemic amyloidosis, proteostasis deficiencies | Recruiting | Not stated | 2026-03-09 | NCT06627309 | |
| Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis | Immunoglobulin Light-chain Amyloidosis, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, amyloidosis, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, primary systemic amyloidosis, proteostasis deficiencies | Recruiting | Phase 2 | 2024-12-30 | NCT06342466 |